Y-Intercept (HK)’s Cytosorbents Corp CTSO Stock Holding History

Y-Intercept (HK)’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,304	Closed	-$31K	–	1021
2022 Q2	$31K	Buy	+14,304	New	+$32.8K	﹤0.01%	774

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Y-Intercept (HK)'s CTSO Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 14,304 shares — an estimated $31K sold.

Y-Intercept (HK) first reported a position in CTSO in Q2 2022 and held it in 1 quarter. The position peaked at $31K in Q2 2022. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

Y-Intercept (HK) reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
Y-Intercept (HK) sold 14,304 Cytosorbents Corp shares in Q3 2022, an estimated $31K.
Y-Intercept (HK) first reported a position in Cytosorbents Corp in Q2 2022 and held it in 1 quarter.
Y-Intercept (HK)'s Cytosorbents Corp position peaked at $31K in Q2 2022.
60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.